Gene · 288
ANK3: ankyrin 3
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. ANK3: ankyrin 3. Genes, record 288. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/288
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q12955 | Ankyrin-3 | 4,377 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents28
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 37427 | Q12955 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2658 | Q12955 | Espacenet |
| US 12433933 B2 | 2025-10-07 | 10 | Q12955 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2658 | Q12955 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 4877 | Q12955 | Espacenet |
| US 11771740 B2 | 2023-10-03 | 10 | Q12955 | Espacenet |
| JP 2022141755 A | 2022-09-29 | 61 | Q12955 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 4877 | Q12955 | Espacenet |
| JP 2022533303 A | 2022-07-22 | 10 | Q12955 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 107848 | Q12955 | Espacenet |
1 to 10 of 28
See all 28 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,921
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ANK3 papers | Newest fiscal year |
|---|---|---|---|
| R01MH107182 | Postsynaptic roles of ankyrins | 11 | 2025 |
| ZIAMH002810 | Functional Genomics of Bipolar Disorder | 7 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 6 | 2025 |
| ZIAMH002843 | Identification of Genes Involved in Major Mood Disorders | 6 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 5 | 2025 |
| P30AG066468 | Alzheimer Disease Research Center | 3 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 3 | 2025 |
| P30CA014195 | Cancer Center Support Grant (CCSG) | 3 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 3 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 3 | 2025 |
1 to 10 of 1,921Source NIH's project files
See all 1,921 nih grantsPapers1,871
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic Programming of Stress-Response Systems: A Systematic Review of How Early Life Stress Shapes Developmental Trajectories of Mental Health. | Dev Psychobiol | 2026 | 42802518 | PubTator, text mining | PubMed |
| Candidate Regulatory Relationship and Expression Correlation Between miR-33a-5p and ANK3 in Chronic Myeloid Leukemia. | Curr Issues Mol Biol | 2026 | 42793305 | PubTator, text mining | PubMed |
| ENaC phosphorylation facilitates ankyrin-3 interaction critical for renal sodium balance. | PNAS Nexus | 2026 | 42568805 | PubTator, text mining | PubMed |
| Molecular determinants of functional voltage-gated sodium (Nav) channel diversity in mammalian central neurons. | J Physiol | 2026 | 42555659 | PubTator, text mining | PubMed |
| Mood and Psychosis Risk-Associated Genes Regulate Neuronal Circadian Rhythms Across the Transcriptome. | Biol Psychiatry | 2026 | 42508743 | PubTator, text mining | PubMed |
| Aberrant neuronal differentiation and splicing defects in Congenital Myotonic Dystrophy (DM1) iPSC models. | bioRxiv | 2026 | 42427665 | PubTator, text mining | PubMed |
| Discovery of a potential novel pharmacogenomic biomarker on ANK3 gene for liafensine, a triple reuptake inhibitor for treatment-resistant depression. | Transl Psychiatry | 2026 | 42321177 | PubTator, text mining | PubMed |
| Epithelial Fucosylation Drives Airway Barrier Dysfunction and Allergic Inflammation via a FUT1 -CDH12 Axis. | Allergy | 2026 | 42305044 | PubTator, text mining | PubMed |
| Dysferlin stabilizes membrane nanodomains of cardiomyocytes after myocardial infarction. | Sci Rep | 2026 | 41882145 | PubTator, text mining | PubMed |
| HAAC Ligation-Enabled Hierarchical Assembly: Deciphering the Synergy of α-Hydroxyl Aldehydes and 2-Aminooxazoles. | J Am Chem Soc | 2026 | 41787607 | PubTator, text mining | PubMed |
1 to 10 of 1,871
See all 1,871 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/288
GET https://conductscience.org/api/genes/v1/288/patents?page=2